Back to trial detailsIntake questionnaire
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
Applying to Abramson Cancer Center of the University of Pennsylvania · Philadelphia, Pennsylvania
Answer a few short questions to share with the research team.
0 of 4 answered